YD Bio Ltd
20-F
April 30, 2026
Key Highlights
- Strategic merger with EG BioMed to consolidate technology and operational contro...
- Established partnerships with industry leaders Novartis, Zuelling, and Alcon.
- Dual-pipeline focus on high-growth sectors: early-stage cancer detection and spe...
Read Analysis
🤖 AI Generated